Heath Weisberg
Caxton Corp
Assets Managed
$4.024M
Holdings
7
Last Quarter
2026 - Q1
Filed Date
1mo 15d ago
Growth Rate
-5.95%(2Q avg: -43.61%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in Caxton Corp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 7 positions.
Assets under management
The assets under management (AUM) of Caxton Corp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 4.024M in assets, with a quarterly growth rate of -5.95% and a 2-quarter average growth rate of -43.61%. The portfolio is managed by Heath Weisberg, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
GLD Spdr Gold Shares
| 81.51% | $3.28M 7,623 shares@ $430.27 avg price | Increased 9.47% |
BRK.B Berkshire Hathaway Inc-cl B
| 8.66% | $348,341 727 shares@ $479.15 avg price | Increased 2.4% |
KYTX Kyverna Therapeutics Inc
| 4.03% | $162,012 18,773 shares@ $8.64 avg price | |
LXEO Lexeo Therapeutics Inc
| 1.99% | $80,032 13,943 shares@ $5.74 avg price | |
XFOR X4 Pharmaceuticals Inc
| 1.6% | $64,249 15,557 shares@ $4.13 avg price | |
IKT Inhibikase Therapeutics Inc
| 1.19% | $47,801 28,453 shares@ $1.68 avg price | |
ALXO Alx Oncology Holdings Inc
| 1.05% | $41,996 20,946 shares@ $2.01 avg price | New Position |
1-7 of 7